This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Gyan Chandra Mishra: Innovator in Osteoporosis Treatment
Introduction
Gyan Chandra Mishra is a notable inventor based in Pune, India. He has made significant contributions to the field of medical science, particularly in the treatment of osteoporosis. His innovative approach has led to the development of a unique method and composition that addresses this prevalent condition.
Latest Patents
Mishra holds a patent for a method and composition for treating osteoporosis. This invention relates to a novel class of acidic amino acid/dicarboxylic acid derivatives, specifically sulfonic acid/sulfate derivatives of naturally occurring amino acids and their amides. These compounds serve as inhibitors of osteoclastogenesis, which is crucial in managing osteoporosis. The patent outlines methods for using these derivatives, represented by the general formula ZOC—(CRR)—COOH, where m can be 2, 3, or 4. The invention provides a promising avenue for the inhibition of osteoclastogenesis, showcasing Mishra's innovative spirit.
Career Highlights
Gyan Chandra Mishra is affiliated with the Council of Scientific & Industrial Research, where he has been instrumental in advancing research in his field. His work has not only contributed to scientific knowledge but also holds potential for practical applications in healthcare.
Collaborations
Mishra has collaborated with esteemed colleagues such as Kanury Venkata Subba Rao and Mohan Ramachandran Wani. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Gyan Chandra Mishra's contributions to the treatment of osteoporosis through his patented methods and compositions highlight his role as a significant innovator in medical science. His work continues to inspire advancements in the field and offers hope for improved treatment options for patients suffering from osteoporosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
